Sunday, March 24, 2019

Johnson & Johnson on Thursday said it will record a nearly $700 million impairment charge in the first quarter of 2019 related to the abandoned development of its experimental antiviral drug, AL-8176.


from Reuters: Health News https://ift.tt/2Tqqdax

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Teens with painful chronic illnesses may find that YouTube can provide a support network, a new study suggests. from Reuters: Health News https://reut.rs/2WgYewj … Read More
  • LATEST HEALTH NEWS(Reuters Health) - People are less likely to take their heart medicine when their local pharmacies close, and the drop-off persists for at least a year, according to a U.S. study. from Reuters: Health News https://reut.r… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Many patients with neurologic disorders like multiple sclerosis, epilepsy and Parkinson's disease have seen steep increases in their out-of-pocket costs for drugs in recent years, a U.S. study suggests. … Read More
  • LATEST HEALTH NEWS(Reuters Health) - Looking online for alternative medicine providers to diagnose or treat celiac disease is a bad idea because many websites market unproven or ineffective tests and treatments, researchers say. from Reut… Read More
  • LATEST HEALTH NEWSMerck & Co said on Wednesday it has increased production of the measles vaccine to meet an uptick in demand in the United States in the midst of the country's biggest outbreak in 25 years. from Reuters: Health News h… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner